oral semaglutide 50 mg VisualAbstract:Oral effectively reduces bodyweight in non-diabetic adults with obesity ✨ 𝐓𝐡𝐢𝐬 𝐖𝐞𝐞𝐤'𝐬 𝐌𝐮𝐬𝐭-𝐑𝐞𝐚𝐝 𝐢𝐧

Remember: Every Womans Journey Is Unique The recommendations in this guide provide general guidance based on current research and expert consensus

When used under medical supervision and combined with healthy lifestyle habits, peptide-based treatments may help support sustainable weight management

In clinical trials, people taking semaglutide lost an average of 15% in a little over a year (even more for those taking Wegovy HD), while those on tirzepatide lost an average of 21% in roughly the same time

Ongoing treatment: If well-tolerated, increase to 0.5 mg once weekly starting from week 5

The average weight loss of patients with a 2.4 mg semaglutide dose reached 9.6% after 12 weeks, 13.8% after six months, and approximately 15% to 20% after a year